TrueSight Ventures

TrueSight Ventures is a UK-based early-stage firm that publishes a website and maintains a Crunchbase profile, but the structured fields in the input do not specify stage, check size, or healthcare focus. The truesight.vc domain and UK LinkedIn registration place it within a London ecosystem that has steadily expanded into digital health, biotech-adjacent software, and AI infrastructure. Without an explicit healthcare line in the firm’s stated thesis, founders should expect a generalist tech orientation with possible openness to AI-driven health applications rather than deep clinical or therapeutic expertise. The likely fit is an AI-native, software-defined company at pre-seed or seed, where the partners can underwrite founder quality and market wedge rather than pharma or device specifics. Healthcare AI founders building clinician productivity, ambient documentation, payer automation, life-sciences analytics, or consumer health platforms with clear UK or European GTM are reasonable candidates. Founders pursuing FDA-cleared devices, multi-year therapeutic platforms, or Series B-plus rounds will find this fund the wrong size and stage. UK seed funds typically write tickets in the GBP 250K to GBP 1.5M range and follow on selectively, so plan dilution and syndicate strategy accordingly. Best entry path is a warm introduction through a portfolio founder or a London ecosystem connector, supplemented by LinkedIn outreach to the managing partner with a tight one-pager and clear ask. Confirm sector appetite in the first call before investing time in a full diligence cycle.